Complete Genomics

Complete Genomics

An established technology leader in whole human genome sequencing.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor

€0.0

round
N/A

€0.0

round

$118m

Valuation: $118m

Acquisition
Total Funding000k
Notes (0)
More about Complete Genomics
Made with AI
Edit

Complete Genomics is a life sciences company that has developed and commercialized a DNA sequencing platform for human genome sequencing and analysis. The company provides comprehensive sequencing solutions catering to both the research and healthcare sectors.

Their core offering is a high-performance sequencing technology with industry-leading accuracy and variant detection. This technology is utilized for whole genome sequencing (WGS), exome sequencing, and other genomic analysis services. The company's business model is centered on the sale of these sequencing solutions and services to a client base that includes research institutions and healthcare providers.

As a subsidiary of MGI, Complete Genomics has a significant U.S. manufacturing footprint and is actively working on diversifying its supply chain and expanding its Next-Generation Sequencing (NGS) capabilities. The company engages in strategic collaborations and partnerships to further its reach and technological advancements in the genomics field.

Keywords: DNA sequencing, human genome, sequencing solutions, life sciences, genomics, whole genome sequencing, variant detection, sequencing technology, MGI, healthcare research

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo